Status:
COMPLETED
Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?
Lead Sponsor:
Wills Eye
Collaborating Sponsors:
Allergan
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfo...
Detailed Description
Continued use of glaucoma drops can alter the outer surface of the eye and result in swelling and irritation, changing the structure of the eye. This structural change has been found to be a significa...
Eligibility Criteria
Inclusion
- Patients with uncontrolled glaucoma scheduled for filtering surgery
Exclusion
- Under 18 years of age
- Unable to understand informed consent
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00405431
Start Date
March 1 2004
End Date
November 1 2007
Last Update
November 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wills Eye Glaucoma Service
Philadelphia, Pennsylvania, United States, 19107